Edition:
United States

Johnson & Johnson (JNJ.N)

JNJ.N on New York Stock Exchange

130.69USD
18 Jan 2019
Change (% chg)

$1.60 (+1.24%)
Prev Close
$129.09
Open
$130.00
Day's High
$131.18
Day's Low
$129.47
Volume
4,326,254
Avg. Vol
2,797,578
52-wk High
$148.97
52-wk Low
$118.62

Chart for

About

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer... (more)

Overall

Beta: 0.56
Market Cap(Mil.): $384,112.91
Shares Outstanding(Mil.): 2,681.98
Dividend: 0.90
Yield (%): 2.51

Financials

  JNJ.N Industry Sector
P/E (TTM): 25.82 29.45 30.88
EPS (TTM): 5.55 -- --
ROI: 12.01 14.34 13.80
ROE: 21.85 15.85 15.29

U.S. lawmaker launches investigation into pharma drug pricing

WASHINGTON A top U.S. lawmaker launched an investigation into pharmaceutical industry pricing practices on Monday, less than a week after he and fellow Democrats introduced legislation aimed at lowering medicine prices.

Jan 14 2019

U.S. lawmaker launches investigation into pharma drug pricing

WASHINGTON, Jan 14 A top U.S. lawmaker launched an investigation into pharmaceutical industry pricing practices on Monday, less than a week after he and fellow Democrats introduced legislation aimed at lowering medicine prices.

Jan 14 2019

Morning News Call - India, January 4

To access the newsletter, click on the link: http://share.thomsonreuters.com/assets/newsletters/Indiamorning/MNC_IN_01042019.pdf If you would like to receive this newsletter via email, please register at: http://financial-risk-solutions.thomsonreuters.info/india-morning FACTORS TO WATCH 11:00 am: Winter Session of Parliament continues in New Delhi. 5:00 pm: RBI to release weekly foreign exchange data in Mumbai. INDIA TOP NEWS • Parliam

Jan 03 2019

U.S. drugmaker J&J's India sales dip 3 percent in 2017/18: filing

NEW DELHI Johnson & Johnson's sales in India dipped 3 percent in the year to March 2018, a regulatory filing showed on Thursday, as the U.S. drugmaker grappled with the country's stringent medical device pricing policies.

Jan 03 2019

U.S. drugmaker J&J's India sales dip 3 percent in 2017/18-filing

NEW DELHI, Jan 3 Johnson & Johnson's sales in India dipped 3 percent in the year to March 2018, a regulatory filing showed on Thursday, as the U.S. drugmaker grappled with the country's stringent medical device pricing policies.

Jan 03 2019

Exclusive: Bangladesh says to collect, test samples of Johnson & Johnson Baby Powder

DHAKA Bangladesh will collect and test samples of Johnson & Johnson's Baby Powder for asbestos in a couple of days, its main testing authority said on Friday, after a Reuters report last Friday that the firm knew for decades that cancer-causing asbestos could be found in the product.

Dec 21 2018

Indian regulator orders J&J to stop using raw material to make Baby Powder in India

NEW DELHI India's drugs regulator has ordered Johnson & Johnson to stop manufacturing its Baby Powder using raw materials in two of its Indian factories until test results prove they are free of asbestos, a senior official said on Thursday.

Dec 21 2018

UPDATE 3-Indian regulator orders J&J to stop using raw material to make Baby Powder in India

* Source says material can't be used unless asbestos is ruled out

Dec 21 2018

Breakingviews - Asia’s beauty giants will apply a western gloss

HONG KONG (Reuters Breakingviews) - Asia’s glamazons can apply a dash of Western colour. Johnson & Johnson, L’Oreal and other giants have splashed out on cutting-edge cosmetics in Japan and Korea, seeking clout and innovation. Yet local beauty brands like Shiseido and snail mask supremo Amorepacific have room to grow too: they can reverse the trend.

Dec 20 2018

Two lawmakers question EPA on asbestos after Reuters report

WASHINGTON Two Democratic U.S. lawmakers have called on the Environmental Protection Agency to answer questions about asbestos exposure after Reuters reported that documents showed Johnson & Johnson knew for decades of the mineral’s presence in its popular baby powder.

Dec 20 2018

Earnings vs. Estimates